Arnica Cream for Hematomas
Arnica cream is not recommended for routine treatment of hematomas based on current evidence, as the majority of well-designed studies show no significant benefit over placebo for bruise resolution.
Evidence Quality and Findings
The available evidence for arnica cream in hematoma treatment is limited and contradictory:
A 2002 randomized, double-blind, placebo-controlled trial found no statistically significant difference between topical arnica gel and vehicle (placebo) in either preventing or resolving laser-induced bruising (P = 0.496 for pretreatment; P = 0.359 for posttreatment groups) 1
A 2010 study showed that 20% arnica ointment demonstrated greater improvement in bruise resolution compared to white petrolatum placebo (P = 0.003), though this was a single positive study among predominantly negative trials 2
A systematic review of the literature concluded there is insufficient data to support the use of arnica post-procedure, with only 4 out of 13 clinical trials on arnica showing any improvement 3
Clinical Context
Homeopathic arnica (Arnica D12) showed only a trend toward benefit in a pilot study of varicose vein surgery patients, with hematoma surface reduction of 75.5% under arnica versus 71.5% under placebo (P = 0.4726), which was not statistically significant 4
The available data is limited and often conflicting, with many physicians using arnica clinically despite the lack of robust evidence 5
Safety Profile
- Tolerability of arnica has been rated as very good in clinical trials, with no serious adverse events reported in the studies reviewed 4, 3
Clinical Recommendation Algorithm
For patients seeking treatment for hematomas:
First-line approach: Direct pressure, elevation (if applicable), and cold therapy remain the evidence-based standard interventions for acute hematomas, as these have established physiological mechanisms
If patient requests arnica: Inform them that evidence does not support its efficacy, though it appears safe if they wish to try it
Consider 20% arnica concentration if used: The single positive study used 20% arnica ointment applied twice daily under occlusion, which showed superiority to lower concentrations 2
Critical Pitfalls
Do not recommend arnica as a proven treatment, as this misrepresents the evidence base—the majority of rigorous trials show no benefit 1, 3
Avoid lower concentration formulations (such as 1% vitamin K with 0.3% retinol), as these performed worse than 20% arnica in comparative studies 2
Do not delay evaluation of concerning hematomas (expanding, associated with compartment syndrome, or in critical locations) while attempting topical treatments 3